BRO · Brown & Brown, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Diluted Net Income Per Share - Adjusted non-GAAP | $2.46 | Six months ended June 30, 2026 | -42.3% |
|
|
|||
| EBITDAC - Adjusted non-GAAP | $598M | Q2 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Income before income taxes 383M
+110M Amortization
+18M Depreciation
+100M Interest
-40M Change in estimated acquisition earn-out payables
+1M (Gain)/loss on disposal
+31M Acquisition/Integration Costs
-5M Mark-to-market of escrow liability
= EBITDAC - Adjusted 598M
|
|||
| EBITDAC Margin - Adjusted non-GAAP | 37.2% | Six months ended June 30, 2026 | +3.6% |
|
|
|||
| Organic Revenue non-GAAP | $2,523M | Six months ended June 30, 2026 | -46.0% |
|
|
|||
| Organic Revenue growth % non-GAAP | -0.3% | Six months ended June 30, 2026 | -110.7% |
|
|
|||
| Organic Revenue with Contingents non-GAAP | $2,658M | Six months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Organic Revenue 1,176M
+61M Organic Contingents
= Organic Revenue with Contingents 1,237M
|
|||
| Organic Revenue with Contingents growth % non-GAAP | 1.6% | Six months ended June 30, 2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance Brokers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRO
this stock
Brown & Brown, Inc.
|
$23.82B | -10.2% | +19.1% | 22.7 | 5.6% |
|
MRSH
Marsh & Mclennan Companies, Inc.
|
$92.24B | +5.9% | +9.7% | 23.6 | 1.4% |
|
AON
Aon plc
|
$76.52B | +2.7% | -0.7% | 19.9 | 2.1% |
|
AJG
Arthur J. Gallagher & Co.
|
$64.66B | -2.1% | +16.6% | 41.8 | 3.1% |
|
WTW
Willis Towers Watson PLC
|
$31.40B | +4.2% | -2.2% | 21.0 | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BRO | +0.4% | +4.9% | +2.7% | +1.1% | -10.2% |
| SPY | +3.6% | +2.2% | +12.8% | +2.9% | +12.7% |
| vs SPY | -3.2% | +2.7% | -10.1% | -1.8% | -22.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.